Stay updated on Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.
Latest updates to the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference2%
- Check36 days agoChange DetectedSeveral links related to Pembrolizumab and clinical trials have been removed, including resources from PubMed and Merck's clinical trials site.SummaryDifference0.3%
- Check43 days agoChange DetectedThe website has been updated to Revision v2.12.2, adding several new resources including links to clinical trial documents and PubMed articles related to Pembrolizumab.SummaryDifference3%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.